Health analytics

Our health and the challenges healthcare systems face are changing. Patients have increasingly complex health needs owing to multimorbidity, and they experience large inequalities in healthcare outcomes. Meanwhile, the assessment of medicines and corresponding payment mechanisms do not reflect the true value that good health brings to healthcare systems and wider society.

With our innovative and market-leading analytics, we aim to enable the transition of health systems globally from importers of illness to exporters of health by realigning value between patients, manufacturers of medicines, payers, and other key stakeholders.

Medicines Nexus™ | Prescription analytics platform

Our innovative prescription analytics platform delivering cutting-edge insights into the medicines market.

Explore now

Our featured insights

View all insights

Shifting health systems from importers of illness to exporters of health

Combining strategic vision with innovative analytics

Our global teams work with clients in the life sciences and healthcare industries, combining our strategic vision with innovative and market leading analytics to support three key transitions:

Moving from single disease focus to holistic assessment of healthcare need, through unmasking increasingly complex, multimorbid, unmet patient needs, to informing targeted action, and improving health equity.
A broader value of medicines and health; re-aligning how Health Technology Assessment bodies and governments value medicines and the value of health to patients, populations, and economies.
Improving health equity through embedding consideration of inequalities across the medicine life cycle.

Long exposure lights of cars driving along a snaking road

Delivering integrated insights that add the most value

We combine our expertise across our service areas to deliver integrated insights that add the most value for our clients. We support clients across the entire innovation lifecycle by:

Transforming real-world healthcare data into actionable insights to guide evidence-based decisions for providers, payers, patients and policymakers – from national institutions like NHS, NIH and CMS to local care teams.
Applying scientific rigour evaluating the economic and clinical value of healthcare interventions to enable patient access.
Developing holistic strategies for global market access and real-world evidence needs to drive commercial success.
Enabling US access by delivering value-based, evidence-driven solutions through deep clinical insight and strategic consulting.
Creating integrated and compelling visual analytics, powered by AI, to support engagement with medical, scientific and policy leaders.
Leveraging large-scale human omics data and cutting-edge analytical techniques to improve the speed and cost-efficiency of drug development.

At LCP we are more than just a service provider – we are your strategic thought partner

We will work with clients from pitch to delivery, with hands on project leadership by senior experts across service areas. Our leadership experience in science, medicine, consulting, pharmaceuticals and policy, and our partnerships with key decision makers, combined with our state-of-the-art technology, methods and expertise, mean we provide insights to tackle the challenges of tomorrow.

Contact us to learn more about how we can bring you clarity and insight in an increasingly complex life sciences and healthcare environment.

Until now there has been limited research on the impact of multi and co-morbidities across different patient groups and how this progresses during the course of the disease. This study has highlighted the large variations in clinical need within the patient group.

Programme director, Data and Real World Evidence National Institute for Health and Care Excellence (NICE)